NewsRack: 'india' news in 'IP' topic for user TahirAmin

Pad up for grades	15.5.2013	The Telegraph : Bihar
The vice-chancellor of Patna University, Arun Kumar Sinha, met principals of colleges to work out a strategy to enable the institutions get better grades from National Assessment and Accreditation Council (Naac) this year.
Also found in: [+]
IT plans to earn more with fewer techies	12.5.2013	Deccan Herald - Supplements
Though information technology (IT) companies in India have been at the forefront of hiring activity, top IT firms this year have deepened their focus on growing non-linear practices in an attempt to wean away the time-tested link between revenues and headcount. The industry has been long dependent on human resources to ramp up revenues. However, these companies are now going the non-linear way to grow revenues. The term non-linearity refers to delinking a companys revenues from headcount and getting higher revenues with lesser dependence on raising employee strength. The IT industry in India is at a point where it faces major difficulties like the end of the tax holiday, competition from MNCs like IBM and Accenture and the traditional labour arbitrage model wearing thin. Industry analysts believe that the industry needs to reinvent itself in order to survive tough competition and a volatile demand economy. In a report titled 'Non-linear models driving the next phase of growth for the ...
Also found in: [+]
How patent wars are hurting IT companies (Cached)	4.5.2013	TOI: All Headlines
How patent wars are hurting IT companies
Also found in: [+]
Dealing with a cussed Pakistan (Cached)	4.5.2013	TOI: Editorial
Dealing with a cussed Pakistan
Also found in: [+]
U.S. trade office hits out at Novartis ruling	2.5.2013	Hindu: Business
‘Appears to confirm that India’s law creates a special, additional criterion for select technologies’
Also found in: [+]
Jaguar wins trademark patent war	2.5.2013	Deccan Chronicle: Business
Chennai: Jaguar Cars Limited of England, owned by Tata Motors, has won the race against Switzerland watchmaker Manufacture Des Montres Jaguar S.A., in a trademark row. The intellectual property appellate board in Chennai on Wednesday quashed the order of the deputy registrar of trademarks,
Also found in: [+]
US slams patent, trade policies (Cached)	2.5.2013	TOI: All Headlines
US slams patent, trade policies
Also found in: [+]
License for Manufacturing Generic Anti-Cancer Drugs (Cached)	30.4.2013	Govt of india: PIB
License for Manufacturing Generic Anti-Cancer Drugs
Also found in: [+]
Meet tomorrow on removing protection for 3 more anti-cancer formulations	29.4.2013	Latest News
The government is being cautious because India is already facing criticism for recent decisions on IPR-related issues
Also found in: [+]
Strong medicine for poor countries	28.4.2013	Top Stories
The Supreme Court decision has given a fillip for greater emphasis on access to medicines worldwide
Also found in: [+]
Little support for pharma MNCs on patent issue (Cached)	27.4.2013	TOI: Intl Business
Multinational drug companies that are complaining against the Indian government and patent authorities using flexibilities under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property rights are finding little support in the international community.
Also found in: [+]
Ever-greening of patents cannot be permitted: DIPP	26.4.2013	Latest News
Amid concerns expressed by multi-national companies over the Supreme Court's judgement in the Novartis case, India today said its laws are WTO compliant and no country could allow "ever-greening" of patents.
Also found in: [+]
U.N body calls for balanced ‘social benefit’ IP regime	24.4.2013	Hindu: Home
This can help reconcile differences:WIPO Director-General
Also found in: [+]
The Rs 700,000 crore question: Who is stalling growth?	21.4.2013	The New Indian Express - The Sunday Standard - http://newindianexpress.com/thesundaystandard/

Also found in: [+]
Without Patented Drugs, There's No Generics Industry: Mylan CEO	20.4.2013	Forbes India
Novartisâe™ and Bayerâe™s patent battles in India reflect the increasing legal nature of the globalising pharma industry, Mylan Inc CEO Heather Bresch tells Forbes India Read more
Also found in: [+]
Keep the doors open for world pharma: Kiran Mazumdar (Cached)	19.4.2013	ET: Opinion
India is now in the position of a thought leader on pharmaceutical patents. But the country cannot afford to lose the moral high ground.
Also found in: [+]
Timely arrival	18.4.2013	Hindu: Home
Road Humps and Sidewalks by Dr. Kalyan Kankanala is a fast-paced legal thriller depicting the veritable battle between generic and patented life-saving drugs
Also found in: [+]
HP Agrawal: Is royalty paid by a non-resident to another taxable in India?	18.4.2013	Business Law & Taxation
The issue for consideration is as to whether the royalty paid by the foreign manufacturers on manufacturing of the goods outside India could also be taxed in India if such goods are sold in India. In terms of section 9(1)(vi)(c), royalty payable by ...
Also found in: [+]
Landmark verdict (Cached)	17.4.2013	Frontline
The Supreme Court’s ruling against Novartis’ patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people.
Also found in: [+]
Of patents & profits	16.4.2013	Deccan Chronicle: Comment
At the heart of the Novartis patent case lie two related questions: Should life-saving medicines be affordable or should they be so priced as to bleed the sick person dry? And, what is a reasonable profit for a company in the health business? While the Supreme Court of India, in its 110-page
Also found in: [+]

1 to 20 of 2,081